Overview
Knowledge about the etiology and diagnosis as well as treatment concepts of neu- oncologic diseases is rapidly growing. This turnover of knowledge makes it dif? cult for the physician engaged in the treatment to keep up to date with current therapies. This book sets out to close the gap and pursues several innovative concepts. As a comprehensive text on neuro-oncology, its chapters are interconnected, but at the same time some chapters or subdivisions are so thoroughly assembled that the whole volume gives the impression of several books combined into one. Neuropathology is treated in an extensive and clearly structured section. The int- ested reader ? nds for each tumor entity the latest well-referenced consensus rega- ing histologic and molecular pathology. Through this “book-in-the-book” concept, information on neuropathology is readily at hand in a concise form and without ov- loading the single chapters. Pediatric neuro-oncology differs in many entities from tumors in adult patients; also, certain tumors of the CNS are typically or mainly found only in the child. Therefore, pediatric neuro-oncology was granted its own, book-like section. Tumor entities that are treated differently in children and adults are included both in the pediatric neuro-oncology section and in the general section. Entities that typically occur only in the child and adolescent are found in the pediatric section in order to avoid redundancies.
Full Product Details
Author: Jörg-Christian Tonn ,
Manfred Westphal ,
J. T. Rutka
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition: 2nd ed. 2010
Dimensions:
Width: 20.30cm
, Height: 3.80cm
, Length: 27.60cm
Weight: 3.095kg
ISBN: 9783642028731
ISBN 10: 364202873
Pages: 793
Publication Date: 15 January 2010
Audience:
Professional and scholarly
,
Professional & Vocational
Replaced By: 9783030041519
Format: Hardback
Publisher's Status: Out of Print
Availability: In Print
Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock.
Reviews
From the reviews of the second edition: Neuro-oncology has benefitted significantly from modern translational research, in particular in the areas related to aggressiveness, invasion, and potential for recurrence. ... Neurosurgeons, neurologists, oncologists, radiation oncologists, radiologists, and practitioners caring for patients with brain tumors are the main audience. ... This is an excellent update. It is a valuable addition to any major academic library and a useful source of management information for neurologists, oncologists, neurosurgeons, radiation oncologists, and all professionals associated with the management of patients with these conditions. (Celso Agner, Doody's Review Service, May, 2010)
From the reviews of the second edition: Neuro-oncology has benefitted significantly from modern translational research, in particular in the areas related to aggressiveness, invasion, and potential for recurrence. ... Neurosurgeons, neurologists, oncologists, radiation oncologists, radiologists, and practitioners caring for patients with brain tumors are the main audience. ... This is an excellent update. It is a valuable addition to any major academic library and a useful source of management information for neurologists, oncologists, neurosurgeons, radiation oncologists, and all professionals associated with the management of patients with these conditions. (Celso Agner, Doody's Review Service, May, 2010)
From the reviews of the second edition: “Neuro-oncology has benefitted significantly from modern translational research, in particular in the areas related to aggressiveness, invasion, and potential for recurrence. … Neurosurgeons, neurologists, oncologists, radiation oncologists, radiologists, and practitioners caring for patients with brain tumors are the main audience. … This is an excellent update. It is a valuable addition to any major academic library and a useful source of management information for neurologists, oncologists, neurosurgeons, radiation oncologists, and all professionals associated with the management of patients with these conditions.” (Celso Agner, Doody’s Review Service, May, 2010)
From the reviews of the second edition: Neuro-oncology has benefitted significantly from modern translational research, in particular in the areas related to aggressiveness, invasion, and potential for recurrence. ! Neurosurgeons, neurologists, oncologists, radiation oncologists, radiologists, and practitioners caring for patients with brain tumors are the main audience. ! This is an excellent update. It is a valuable addition to any major academic library and a useful source of management information for neurologists, oncologists, neurosurgeons, radiation oncologists, and all professionals associated with the management of patients with these conditions. (Celso Agner, Doody's Review Service, May, 2010)
